Literature DB >> 20826314

Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS.

Takeshi Nishijima1, Joaquin Piriz, Sylvie Duflot, Ana M Fernandez, Gema Gaitan, Ulises Gomez-Pinedo, Jose M Garcia Verdugo, Felix Leroy, Hideaki Soya, Angel Nuñez, Ignacio Torres-Aleman.   

Abstract

Upon entry into the central nervous system (CNS), serum insulin-like growth factor-1 (IGF-I) modulates neuronal growth, survival, and excitability. Yet mechanisms that trigger IGF-I entry across the blood-brain barrier remain unclear. We show that neuronal activity elicited by electrical, sensory, or behavioral stimulation increases IGF-I input in activated regions. Entrance of serum IGF-I is triggered by diffusible messengers (i.e., ATP, arachidonic acid derivatives) released during neurovascular coupling. These messengers stimulate matrix metalloproteinase-9, leading to cleavage of the IGF binding protein-3 (IGFBP-3). Cleavage of IGFBP-3 allows the passage of serum IGF-I into the CNS through an interaction with the endothelial transporter lipoprotein related receptor 1. Activity-dependent entrance of serum IGF-I into the CNS may help to explain disparate observations such as proneurogenic effects of epilepsy, rehabilitatory effects of neural stimulation, and modulatory effects of blood flow on brain activity. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826314     DOI: 10.1016/j.neuron.2010.08.007

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  103 in total

Review 1.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

2.  Brain glycogen supercompensation following exhaustive exercise.

Authors:  Takashi Matsui; Taro Ishikawa; Hitoshi Ito; Masahiro Okamoto; Koshiro Inoue; Min-Chul Lee; Takahiko Fujikawa; Yukio Ichitani; Kentaro Kawanaka; Hideaki Soya
Journal:  J Physiol       Date:  2011-11-07       Impact factor: 5.182

Review 3.  Physical exercise, neuroplasticity, spatial learning and memory.

Authors:  Ricardo C Cassilhas; Sergio Tufik; Marco Túlio de Mello
Journal:  Cell Mol Life Sci       Date:  2015-12-08       Impact factor: 9.261

Review 4.  The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.

Authors:  Jesse Costales; Alexander Kolevzon
Journal:  Neurosci Biobehav Rev       Date:  2016-01-15       Impact factor: 8.989

5.  Therapeutic potential of IGF-I on hippocampal neurogenesis and function during aging.

Authors:  Gustavo R Morel; Micaela López León; Maia Uriarte; Paula C Reggiani; Rodolfo G Goya
Journal:  Neurogenesis (Austin)       Date:  2016-12-20

6.  Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence.

Authors:  Han Yan; Matthew Mitschelen; Georgina V Bixler; Robert M Brucklacher; Julie A Farley; Song Han; Willard M Freeman; William E Sonntag
Journal:  J Endocrinol       Date:  2011-07-12       Impact factor: 4.286

7.  β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome.

Authors:  Nikolaos Mellios; Jonathan Woodson; Rodrigo I Garcia; Benjamin Crawford; Jitendra Sharma; Steven D Sheridan; Stephen J Haggarty; Mriganka Sur
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

8.  Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome.

Authors:  Jorge Castro; Rodrigo I Garcia; Showming Kwok; Abhishek Banerjee; Jeremy Petravicz; Jonathan Woodson; Nikolaos Mellios; Daniela Tropea; Mriganka Sur
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

Review 9.  Cell-culture models of the blood-brain barrier.

Authors:  Yarong He; Yao Yao; Stella E Tsirka; Yu Cao
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

10.  Nutrition, insulin-like growth factor-1 and retinopathy of prematurity.

Authors:  Anna-Lena Hård; Lois E Smith; Ann Hellström
Journal:  Semin Fetal Neonatal Med       Date:  2013-02-18       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.